APA (7th ed.) Citation

Toshiki Murasaka, Kenji Ikemura, Tomoyuki Enokiya, Yuichi Muraki, Mayumi Ikemura, Koji Terada, . . . Masahiro Okuda. (2017). Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza. BMC.

Chicago Style (17th ed.) Citation

Toshiki Murasaka, Kenji Ikemura, Tomoyuki Enokiya, Yuichi Muraki, Mayumi Ikemura, Koji Terada, Takuya Iwamoto, and Masahiro Okuda. Impact of the Number of Repeated Inhalations and Patient Characteristics on the Residual Amount of Inhaled Laninamivir Octanoate Hydrate Dry Powder in Pediatric Patients with Influenza. BMC, 2017.

MLA (9th ed.) Citation

Toshiki Murasaka, et al. Impact of the Number of Repeated Inhalations and Patient Characteristics on the Residual Amount of Inhaled Laninamivir Octanoate Hydrate Dry Powder in Pediatric Patients with Influenza. BMC, 2017.